JP2005530744A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530744A5
JP2005530744A5 JP2004500775A JP2004500775A JP2005530744A5 JP 2005530744 A5 JP2005530744 A5 JP 2005530744A5 JP 2004500775 A JP2004500775 A JP 2004500775A JP 2004500775 A JP2004500775 A JP 2004500775A JP 2005530744 A5 JP2005530744 A5 JP 2005530744A5
Authority
JP
Japan
Prior art keywords
amiodarone
sae
formulation
independently
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004500775A
Other languages
English (en)
Japanese (ja)
Other versions
JP4764004B2 (ja
JP2005530744A (ja
Filing date
Publication date
Priority claimed from US10/139,620 external-priority patent/US6869939B2/en
Application filed filed Critical
Publication of JP2005530744A publication Critical patent/JP2005530744A/ja
Publication of JP2005530744A5 publication Critical patent/JP2005530744A5/ja
Application granted granted Critical
Publication of JP4764004B2 publication Critical patent/JP4764004B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004500775A 2002-05-04 2003-04-29 アミオダロンおよびスルホアルキルエーテルシクロデキストリンを含む製剤 Expired - Lifetime JP4764004B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/139,620 2002-05-04
US10/139,620 US6869939B2 (en) 2002-05-04 2002-05-04 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
PCT/US2003/013250 WO2003092590A2 (en) 2002-05-04 2003-04-29 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011048873A Division JP5656692B2 (ja) 2002-05-04 2011-03-07 アミオダロンおよびスルホアルキルエーテルシクロデキストリンを含む製剤

Publications (3)

Publication Number Publication Date
JP2005530744A JP2005530744A (ja) 2005-10-13
JP2005530744A5 true JP2005530744A5 (enExample) 2006-06-15
JP4764004B2 JP4764004B2 (ja) 2011-08-31

Family

ID=29399340

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004500775A Expired - Lifetime JP4764004B2 (ja) 2002-05-04 2003-04-29 アミオダロンおよびスルホアルキルエーテルシクロデキストリンを含む製剤
JP2011048873A Expired - Lifetime JP5656692B2 (ja) 2002-05-04 2011-03-07 アミオダロンおよびスルホアルキルエーテルシクロデキストリンを含む製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011048873A Expired - Lifetime JP5656692B2 (ja) 2002-05-04 2011-03-07 アミオダロンおよびスルホアルキルエーテルシクロデキストリンを含む製剤

Country Status (16)

Country Link
US (1) US6869939B2 (enExample)
EP (2) EP2402008B1 (enExample)
JP (2) JP4764004B2 (enExample)
KR (1) KR100984197B1 (enExample)
AT (1) ATE535239T1 (enExample)
AU (1) AU2003234285B2 (enExample)
CA (1) CA2483774C (enExample)
CY (1) CY1112527T1 (enExample)
DK (2) DK2402008T3 (enExample)
ES (2) ES2567716T3 (enExample)
HU (1) HUE027551T2 (enExample)
IL (2) IL165022A0 (enExample)
MX (1) MXPA04010925A (enExample)
PT (1) PT1501496E (enExample)
SI (2) SI2402008T1 (enExample)
WO (1) WO2003092590A2 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1713504T (pt) 2004-01-30 2017-08-29 Zoetis Services Llc Conservantes antimicrobianos para obter uma formulação multidose utilizando beta-ciclodextrinas para formas galénicas líquidas
CN101098678A (zh) 2004-04-23 2008-01-02 锡德克斯公司 含有磺基烷基醚环糊精的dpi制剂
US8092559B2 (en) 2004-05-12 2012-01-10 Luca Technologies, Inc. Generation of hydrogen from hydrocarbon bearing materials
US7426960B2 (en) 2005-05-03 2008-09-23 Luca Technologies, Inc. Biogenic fuel gas generation in geologic hydrocarbon deposits
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US7416879B2 (en) 2006-01-11 2008-08-26 Luca Technologies, Inc. Thermacetogenium phaeum consortium for the production of materials with enhanced hydrogen content
BRPI0709409A2 (pt) 2006-03-28 2011-07-12 Javelin Pharmaceuticals Inc composição farmacêutica e método para tratar um mamìfero necessitando de analgesia
EP2003970A4 (en) 2006-03-28 2012-07-11 Javelin Pharmaceuticals Inc FORMULATIONS OF LOW-DOSEED NON-STEROID INFLAMMATORY INHIBITORS AND BETA-CYCLODEXTRIN
US7977282B2 (en) 2006-04-05 2011-07-12 Luca Technologies, Inc. Chemical amendments for the stimulation of biogenic gas generation in deposits of carbonaceous material
US7696132B2 (en) 2006-04-05 2010-04-13 Luca Technologies, Inc. Chemical amendments for the stimulation of biogenic gas generation in deposits of carbonaceous material
US20090239942A1 (en) 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
PT2061458E (pt) * 2006-09-15 2015-03-11 Univ Minnesota Composições de topiramato e métodos para a sua utilização
US20090270496A1 (en) * 2007-05-03 2009-10-29 Courchesne William E Antifungal compounds
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US8479813B2 (en) 2009-12-16 2013-07-09 Luca Technologies, Inc. Biogenic fuel gas generation in geologic hydrocarbon deposits
EP2335686A1 (en) 2009-12-21 2011-06-22 LEK Pharmaceuticals d.d. An aqueous intravenous nanosuspension with reduced adverse effects
NL2004260C2 (en) * 2010-02-18 2011-08-22 Univ Amsterdam Disinfectant composition and its use in dental treatment.
AU2011264919A1 (en) * 2010-06-11 2013-01-10 Baxter Healthcare S.A. Formulations including amiodarone and salts thereof and methods of their manufacture and use
EP2734212B1 (en) 2011-07-20 2017-09-06 Hospira, Inc. Compositions comprising diclofenac for the treatment of post-operative pain
SG11201401597TA (en) 2011-11-29 2014-05-29 Jurox Pty Ltd Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
EP3415153A1 (en) * 2012-01-30 2018-12-19 Baxalta GmbH Non-anticoagulant sulfated or sulfonated polysaccharides
PL3702374T3 (pl) 2012-02-15 2022-11-21 Cydex Pharmaceuticals, Inc. Sposób wytwarzania pochodnych cyklodekstryny
WO2013130666A1 (en) 2012-02-28 2013-09-06 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
US9004162B2 (en) 2012-03-23 2015-04-14 Transworld Technologies Inc. Methods of stimulating acetoclastic methanogenesis in subterranean deposits of carbonaceous material
CA2887057A1 (en) * 2012-10-17 2014-04-24 Sapiotec Gmbh Anthocyanidin complex for the treatment of multiple myeloma
UA121095C2 (uk) 2012-10-22 2020-04-10 Сідекс Фармасьютікалс, Інк. Композиції алкілованого циклодекстрину і способи їх одержання і застосування
CN104870001B (zh) * 2012-11-15 2019-01-18 赛博尔泰克股份公司 用作消炎或免疫抑制有效成分的飞燕草素络合物
EP2773033B1 (en) 2013-02-28 2018-12-05 Dialog Semiconductor GmbH Divide by 2 and 3 charge pump methods
GB201312737D0 (en) 2013-07-17 2013-08-28 Univ Greenwich Cyclodextrin
EP3183295B1 (en) 2014-08-22 2023-08-02 CyDex Pharmaceuticals, Inc. Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
US10736891B2 (en) * 2016-01-07 2020-08-11 Roy MADIGAN Composition and method for treating chagas disease
US11166911B2 (en) * 2016-03-04 2021-11-09 Sun Pharmaceutical Industries Limited Parenteral dosage form of amiodarone
CN107753439A (zh) * 2016-08-22 2018-03-06 黑龙江迪龙制药有限公司 一种注射用盐酸胺碘酮及其制备方法
CA3043979A1 (en) 2016-11-18 2018-05-24 Aicuris Anti-Infective Cures Gmbh Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and acidifying agents, their preparation and use as antimicrobial pharmaceutical compositions
US12416024B2 (en) 2018-03-29 2025-09-16 Transworld Technologies Inc. Biologically enhanced oil recovery methods
WO2020232274A1 (en) * 2019-05-15 2020-11-19 Bexson Biomedical, Inc. Ketamine formulation for subcutaneous injection
CA3149914A1 (en) 2019-08-06 2021-02-11 L.E.A.F. Holdings Group Llc Processes of preparing polyglutamated antifolates and uses of their compositions
JP2023551145A (ja) 2020-11-18 2023-12-07 ベクソン バイオメディカル,インク. 医薬化合物の錯化剤塩製剤
CN115969833A (zh) * 2023-01-03 2023-04-18 上海上药第一生化药业有限公司 胺碘酮药物组合物、注射液及其制备方法及含其的注射器

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004026A1 (en) 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
EP0518930A4 (en) 1990-03-02 1993-09-15 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
US5234949A (en) 1992-04-01 1993-08-10 Academic Pharmaceuticals, Inc. Parenteral solutions containing amiodarone in acetate buffer solution
FR2735978B1 (fr) * 1995-06-30 1997-09-19 Sanofi Sa Composition pharmaceutique d'amiodarone pour administration parenterale
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
US5916883A (en) 1996-11-01 1999-06-29 Poly-Med, Inc. Acylated cyclodextrin derivatives
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
EE200100382A (et) 1999-01-21 2002-12-16 Bristol-Myers Squibb Company Ras-farnesüültransferaasi inhibiitori ja sulfobutüüleeter-7-ß-tsüklodekstriini või 2-hüdroksüpropüül-ß-tsüklodekstriini kompleks ja selle valmistamise meetod
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB9921958D0 (en) * 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
US6479541B1 (en) * 2000-03-30 2002-11-12 Baxter International Amiodarone-containing parenteral administration

Similar Documents

Publication Publication Date Title
JP2005530744A5 (enExample)
CA2483774A1 (en) Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
US20200054766A1 (en) Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
JP2000513029A (ja) ボリコナゾールを含有する薬剤製剤
JP2010524963A5 (enExample)
ES2329477T3 (es) Formulacion de una composicion insecticida sinergica como un complejo de ciclodextrina.
JPH0257049B2 (enExample)
CZ20031612A3 (cs) Farmaceutický prostředek pro parenterální podání
JPH05271053A (ja) 安定な点眼剤
CN113768874B (zh) 一种复合碘消毒液及其制备方法
CA2400133C (en) Anaesthetic composition
CN114903044A (zh) 一种抗病毒消毒剂及其制备方法与应用
JP4132807B2 (ja) ヨウ素系濃縮防殺菌剤組成物
JP4409854B2 (ja) ヨウ素安定化担体、非水溶性固体及び非水溶性固体の製造方法
JPS5938923B2 (ja) ヨ−ドホ−ル殺菌剤
JPH0149125B2 (enExample)
RU2006139065A (ru) Композиции с замаскированным вкусом, содержащие сертралин и простой сульфоалкиловый эфир циклодекстрина
JPH11513701A (ja) N−[4−オキソ−2−(1h−テトラゾール−5−イル)−4h−1−ベンゾピラン−8−イル]−4−(4−フェニルブトキシ)ベンズアミドの塩
AU3901801A (en) Anaesthetic composition